Anaphylaxis Update for Health Professionals Webinar 2021

Anaphylaxis Update for Health Professionals

To help inform healthcare professionals, a webinar was conducted by the National Allergy Strategy in partnership with the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia on Wednesday Thursday 18 November 2021.

The expert panel included:

Dr Katie Frith
Maria Said
Briony Tyquin

The webinar

Provides information about EpiPen® and Anapen®, demonstrates use of both devices and explains what resources are available.
Provides information about the new ASCIA Action Plans.
Help you support your patients at risk of anaphylaxis.
The expert panel answered your questions.

Full webinar

Questions

Content created December 2021

Anaphylaxis Update for Health Professionals Webinar 2021

Anaphylaxis Update for Health Professionals

Full webinar

Anaphylaxis Update for Health Professionals Webinar - full version

Questions

When we teach patients how to use Anapen®, should we be teaching them to recap it?

Is there a cost difference between the Anapen® and EpiPen®?

I believe there is another brand available, SYMJEPI, is that correct?

Will schools and childcare have both the EpiPen and Anapen® as their general use pens going forward, or do they choose one or the other?

Is there a difference between the shelf-life of EpiPen and Anapen®? Is Anapen® replacing EpiPen® or is EpiPen® going to continue to be available?

My staff have completed the two-yearly anaphylaxis training earlier in the year, do they need to retrain due to Anapen®? When do you recommend that staff train on Anapen®?

Can my child’s school refuse to accept Anapen®?

Do we need to have two pens at hands, always, if necessary?

Should we be prescribing older teens an Anapen® 500 now, even though they’ve had EpiPen® in the past?

When should ASCIA Actions Plans be updated?

Do we need to complete a Drug Allergy Action Plan if the patient has other allergies such as a food allergy?

What are the different doses of EpiPen® and Anapen®?

Is the duration of effect the same for both devices?

What resources are available to patients to help them understand about the two devices that are on the market?

I see the Anapen® needle is smaller and thinner than the EpiPen®. Would this be seen to be more beneficial in young children?

Can a first aider administer more than two doses without advice from an emergency service, as long as they’re waiting the five-minute spacing between them?

If the child has an Anapen®, and you’ve given them their Anapen®, but they need a second dose, can you use an EpiPen®?

Is there any advantage of the Anapen® over the EpiPen® and vice versa?